课题基金 / 基金详情

Efficient microarray meta analysis and cancer biomarker selection

Efficient microarray meta analysis and cancer biomarker selection
高效的微阵列荟萃分析和癌症生物标志物选择
批准号:
7685435
负责人:
Shuangge Ma
金额:
$7.91万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-09-01 至 2011-08-31

项目摘要

项目成果

Shuangge Ma的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):
英文摘要
DESCRIPTION (provided by applicant): An important goal in cancer research is to identify genomic biomarkers that can be used to obtain a better understanding of the genetic basis of cancers, and construct models that can be used to predict cancer occurrence and progression. Many studies have used microarrays to identify genes that have altered expression levels in various cancer tissues. Meta analysis makes it possible to (1) effectively combine experiments with different microarray platforms and/or other setup; (2) lead to more reliable and consistent gene identification results across studies and more satisfactory predictions; and (3) identify genes that are commonly activated in different types of cancer. The proposed study is the first to investigate novel regularized methods for microarray meta analysis where cancer clinical outcomes are measured along with gene expressions in multiple independent experiments. The proposed approaches can (1) effectively combine data from different platforms/ experimental setup; (2) carry out efficient biomarker selection and predictive model building simultaneously; and (3) identify influential genes that are important across different experiments, while allowing for experiment-specific predictive models. The specific aims of this study include: (1) Develop MTGDR (Meta Threshold Gradient Directed Regularization) method for regularized microarray meta analysis. (2) Develop penalized group-bridge method for regularized microarray meta analysis. (3) Apply the proposed general methodologies to cancer classification and survival analysis with microarray data. Develop user-friendly R packages implementing the proposed approaches and make them publicly available. We will consider cancer microarray meta analysis where individual experiments can have categorical clinical outcomes and right censored survival outcomes. Analysis of practical cancer studies and extensive simulations will be conducted to assess performance of proposed approaches and compare with alternatives. In this application, we emphasize not only development of new general methodologies, but also their computer implementation, applications and empirical performances.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cancer Emulation Analysis with Deep Neural Network
  • 批准号:
    10725293
  • 项目类别:
  • 资助金额:
    $16.75万
  • 财政年份:
    2023
  • 负责人:
    Shuangge Ma
  • 依托单位:
Deep Learning-based Emulation Analysis: Methodological Developments and Case Studies
  • 批准号:
    10515491
  • 项目类别:
  • 资助金额:
    $12.56万
  • 财政年份:
    2022
  • 负责人:
    Shuangge Ma
  • 依托单位:
Deep Learning-based Emulation Analysis: Methodological Developments and Case Studies
  • 批准号:
    10676303
  • 项目类别:
  • 资助金额:
    $12.56万
  • 财政年份:
    2022
  • 负责人:
    Shuangge Ma
  • 依托单位:
Integrated Cancer Modeling: A New Dimension
  • 批准号:
    9812144
  • 项目类别:
  • 资助金额:
    $8.38万
  • 财政年份:
    2019
  • 负责人:
    Shuangge Ma
  • 依托单位:
海外基金